Truist Securities Reiterates Buy on Amgen, Maintains $320 Price Target

Amgen Inc. -0.22%

Amgen Inc.

AMGN

305.84

-0.22%

Truist Securities analyst Robyn Karnauskas reiterates Amgen (NASDAQ: AMGN) with a Buy and maintains $320 price target.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via